205 related articles for article (PubMed ID: 23408960)
21. Thy-1
Schliekelman MJ; Creighton CJ; Baird BN; Chen Y; Banerjee P; Bota-Rabassedas N; Ahn YH; Roybal JD; Chen F; Zhang Y; Mishra DK; Kim MP; Liu X; Mino B; Villalobos P; Rodriguez-Canales J; Behrens C; Wistuba II; Hanash SM; Kurie JM
Sci Rep; 2017 Jul; 7(1):6478. PubMed ID: 28744021
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic vessel density and lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
[TBL] [Abstract][Full Text] [Related]
23. Blood vessels expressing CD90 in human and rat brain tumors.
Inoue A; Tanaka J; Takahashi H; Kohno S; Ohue S; Umakoshi A; Gotoh K; Ohnishi T
Neuropathology; 2016 Apr; 36(2):168-80. PubMed ID: 26350700
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of novel dermal Thy-1 antigen-bearing dendritic cells in murine skin.
Tamaki K; Yasaka N; Chang CH; Ohtake N; Saitoh A; Nakamura K; Furue M
J Invest Dermatol; 1996 Mar; 106(3):571-5. PubMed ID: 8648196
[TBL] [Abstract][Full Text] [Related]
25. Absence of lymphatic vessels in human dental pulp: a morphological study.
Gerli R; Secciani I; Sozio F; Rossi A; Weber E; Lorenzini G
Eur J Oral Sci; 2010 Apr; 118(2):110-7. PubMed ID: 20486999
[TBL] [Abstract][Full Text] [Related]
26. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract][Full Text] [Related]
27. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
28. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
[TBL] [Abstract][Full Text] [Related]
29. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells.
Chung MT; Liu C; Hyun JS; Lo DD; Montoro DT; Hasegawa M; Li S; Sorkin M; Rennert R; Keeney M; Yang F; Quarto N; Longaker MT; Wan DC
Tissue Eng Part A; 2013 Apr; 19(7-8):989-97. PubMed ID: 23216074
[TBL] [Abstract][Full Text] [Related]
30. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
31. Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway.
Yücel YH; Johnston MG; Ly T; Patel M; Drake B; Gümüş E; Fraenkl SA; Moore S; Tobbia D; Armstrong D; Horvath E; Gupta N
Exp Eye Res; 2009 Nov; 89(5):810-9. PubMed ID: 19729007
[TBL] [Abstract][Full Text] [Related]
32. Topographic study on nerve-associated lymphatic vessels in the murine craniofacial region by immunohistochemistry and electron microscopy.
Furukawa M; Shimoda H; Kajiwara T; Kato S; Yanagisawa S
Biomed Res; 2008 Dec; 29(6):289-96. PubMed ID: 19129672
[TBL] [Abstract][Full Text] [Related]
33. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
[TBL] [Abstract][Full Text] [Related]
34. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
35. Extensive CD34-to-CD90 Fibroblast Transition Defines Regions of Cutaneous Reparative, Hypertrophic, and Keloidal Scarring.
Ho JD; Chung HJ; Ms Barron A; Ho DA; Sahni D; Browning JL; Bhawan J
Am J Dermatopathol; 2019 Jan; 41(1):16-28. PubMed ID: 30320623
[TBL] [Abstract][Full Text] [Related]
36. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
Elife; 2020 Sep; 9():. PubMed ID: 32897857
[TBL] [Abstract][Full Text] [Related]
37. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels.
Gordon EJ; Gale NW; Harvey NL
Dev Dyn; 2008 Jul; 237(7):1901-9. PubMed ID: 18570254
[TBL] [Abstract][Full Text] [Related]
38. Cardiac mouse lymphatics: developmental and anatomical update.
Flaht-Zabost A; Gula G; Ciszek B; Czarnowska E; Jankowska-Steifer E; Madej M; Niderla-Bielińska J; Radomska-Leśniewska D; Ratajska A
Anat Rec (Hoboken); 2014 Jun; 297(6):1115-30. PubMed ID: 24700724
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in mice.
Liang Q; Ju Y; Chen Y; Wang W; Li J; Zhang L; Xu H; Wood RW; Schwarz EM; Boyce BF; Wang Y; Xing L
Arthritis Res Ther; 2016 Mar; 18():62. PubMed ID: 26970913
[TBL] [Abstract][Full Text] [Related]
40. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S
J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
